Semaglutide Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes, and an anti-obesity medication used for weight management
Overview of GLP-1 Receptor Agonists The major GLP-1 receptor agonists available on the market currently are: Dulaglutide (Trulicity) Exenatide extended release (Bydureon BCise) Exenatide (Byetta) Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) What is Dulaglutide (Trulicity) and its mechanism of action Dulaglutide, sold as Trulicity, is an injectable GLP-1 receptor agonist medication designed for the treatment of type 2 diabetes
Weight fluctuations during and after illness are usually due to temporary factors: hydration changes, inflammation, reduced activity, and altered eating patterns
If you feel your current dose is not working, the right step is to discuss it with your provider at your next scheduled follow-up
Avoid lengthy waits for appointments by connecting with a provider within a day through our telehealth platform
Unlocking Weight Loss with Semaglutide: A Safe and Effective Solution In the ever-evolving landscape of weight loss solutions, Semaglutide has emerged as a groundbreaking option, offering hope to many who struggle with obesity and weight-related health issues